Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. - Wikidata - awgldk - TriplyDB

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

http://www.wikidata.org/entity/Q35156568

about

Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Long-term prognosis after resection of cryptogenic hepatocellular carcinoma Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.The androgen receptor as an emerging target in hepatocellular carcinoma Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.Impact of smoking habit on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma.Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.Diffuse fatty metamorphosis of a large, well-differentiated hepatocellular carcinoma originating in the normal liver: a case report and literature review.Optimizing care for the obese patient in interventional radiology Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.Associations of Antibody to Hepatitis B Core Antigen-positivity with Outcomes in Hepatocellular Carcinoma Patients Undergoing Hepatic Resection.Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV Clinical characteristics and prognosis of non-B non-C hepatocellular carcinoma patients with modest alcohol consumption.Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.Clinical characteristics of patients with diabetes mellitus and fatty liver diagnosed by liver/spleen Hounsfield units on CT scan Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas.Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma.Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis.Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B.A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapy

P2860

Q28066295-6E2118F9-0C40-447B-82A1-5E112C193F3F Q30234736-B58A4B60-338B-4AF8-990A-DCBC7CF6BA08 Q35811052-CD57C3E4-F56C-4360-835F-DA6BAAE3D972 Q36652018-FC05F477-C68D-40EE-9ECD-52924E97BB35 Q37031766-0F8BFCA9-16E5-473B-9B2B-D9AF615C4EFC Q37588455-750FA07F-8205-4D2E-8794-0FD7BC6DEC82 Q37619833-79CA0893-7314-403B-95F2-772A17221F39 Q37672219-0AEBF763-C7B9-4BCD-83A3-CF0FB50E3F26 Q38313236-103143FD-A3E4-4E92-A899-E685078B7C94 Q38594893-0C5A9DEF-E896-4D4D-BF1D-0B4B6C876D98 Q39084404-BB2E35B9-D6F6-4EBF-9753-6412B4D57FB8 Q39970001-14D8FB6D-2552-4F42-80DF-85D092067BE2 Q40108180-0802AFA5-DAAE-45B7-A756-278230425F2E Q40121871-98E2412E-FAAE-42B1-A8DA-698A659A6BE8 Q40228687-46C60A4B-A8AF-4674-94DB-B359B1CF1E15 Q40627507-83890220-9701-4645-9E64-DA88CAE889F2 Q41054698-38AE9D32-557D-48F1-BDE9-8CB65124D9D7 Q41235262-EE0C08BD-AE85-4DCB-94A8-24C61848D07A Q41505555-B8F28E70-4E97-4427-AEE2-024D487DFDBF Q42089836-55885319-BE31-4742-BDBE-61CE0A67AF9C Q42376278-C7858315-3AAE-4BCD-9AC8-D78A14939EE7 Q47550148-A6A56A66-501E-484C-BEA9-D88170F2BB4A Q47559332-DA7124B9-1FDD-472A-B940-DF947DF05636 Q49884608-9B8A703A-D82A-4114-A2C9-E5EB8A0C68DB Q51579117-96748298-1D3D-47D6-A5D6-AF22C505A2E0 Q52717218-7C17925A-0CD2-4224-8577-E963AA08FD85 Q55258217-CC32D7BB-65C0-4293-8644-A7F68778853C Q55562058-C1287C6E-5400-4972-998D-A938FA1FDC66 Q57491231-2589CEBD-15E8-4444-A34E-69052F76E9FD

P2860

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

http://www.wikidata.org/entity/Q35156568

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical characteristics, trea ...... tive multicenter cohort study.

@ast

Clinical characteristics, trea ...... tive multicenter cohort study.

@en

type

label

Clinical characteristics, trea ...... tive multicenter cohort study.

@ast

Clinical characteristics, trea ...... tive multicenter cohort study.

@en

prefLabel

Clinical characteristics, trea ...... tive multicenter cohort study.

@ast

Clinical characteristics, trea ...... tive multicenter cohort study.

@en

P1433

Q35156568-E26F88A2-37E5-4B76-8706-D175430019A6

P1476

Q35156568-829B9DBC-7547-4486-8AEA-D15F5303376D

P2093

Q35156568-3AD370C6-0756-4AEC-8C74-8DDA58C1E032

Q35156568-64A0ABC9-391F-4557-B39D-DEC9BE8C3053

Q35156568-8B259CA6-C25B-4D6E-B27F-D598B251AD52

Q35156568-AA05D7BF-A008-4F50-80A7-E032120DC25E

Q35156568-B7D0D795-314E-436D-AA5B-0138DC963250

Q35156568-E7B286DA-6328-4B98-91D0-824E18B3FD4E

P2860

Q35156568-29736B88-747F-45A7-90E6-017329DA1C9B

Q35156568-315D8703-C736-42B4-AEFD-61A6CF61940D

Q35156568-34AACAF2-280C-4753-901A-916706F51668

Q35156568-37CA071C-A2C2-4492-A10A-CDD9D61AB339

Q35156568-3EA33FE5-2AA9-4856-9466-2BC848D134E2

Q35156568-4D254E85-E6CC-4F06-BB8E-D7B849DB3525

Q35156568-5AF74CEA-CB8B-4B1A-B233-F4FDDC84F4C2

Q35156568-63134D62-83F0-44DF-BC3B-6980FF4D3F55

Q35156568-74B4A556-35A9-4EFA-8745-2DC4BD26B01F

Q35156568-7E9E86A9-0BB9-42CF-AD71-7028D3C36B43

P304

Q35156568-0DB08166-D569-43F9-A6A4-011C1AD3D0AD

P31

Q35156568-B6CA0545-7DFD-4CAA-843C-2A24F1CD4118

P356

Q35156568-8F2F98FA-AD86-4D0E-8C43-6F36A9E3383E

P433

Q35156568-3A369963-85CD-4C10-B08B-3632A0869BA0

P478

Q35156568-3F904EBD-F60E-47C3-B22D-2042D1AD3D79

P50

Q35156568-0BCBB334-41E1-43BA-A3F2-E21766831A26

Q35156568-60827ED1-2E6C-4808-BF87-F3D123624627

Q35156568-B6D5CA4D-61A8-4089-94E4-8C2236CAA037

P577

Q35156568-96706FCC-8D6A-4428-A5F9-A65288754228

P5875

Q35156568-A2D89D0F-0EA7-4F47-87C8-CC418CFD0442

P698

Q35156568-F2B5D9B5-0CEE-47FC-BCEB-6B0383CD30B3

P921

Q35156568-07540907-3046-4CEE-863E-2A4C69351683

P932

Q35156568-5DC3AD78-C547-4EDC-9047-F5336926DF63

P356

S00535-014-0973-8

P1433

Journal of Gastroenterology

P1476

Clinical characteristics, trea ...... ctive multicenter cohort study

@en

P2093

Hiromitsu Kumada

http://www.w3.org/2001/XMLSchema#string

Kendo Kiyosawa

http://www.w3.org/2001/XMLSchema#string

Kiwamu Okita

http://www.w3.org/2001/XMLSchema#string

Masao Omata

http://www.w3.org/2001/XMLSchema#string

Norio Hayashi

http://www.w3.org/2001/XMLSchema#string

Takeshi Okanoue

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

The global health burden of infection-associated cancers in the year 2002

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

P304

350-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00535-014-0973-8

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Ryosuke Tateishi

P577

2014-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263095553

http://www.w3.org/2001/XMLSchema#string

P698

24929638

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4352653

http://www.w3.org/2001/XMLSchema#string